Mesoblast Limited (MESO)
NASDAQ: MESO · Real-Time Price · USD
17.19
-0.06 (-0.35%)
Feb 2, 2026, 4:00 PM EST - Market closed
Mesoblast Market Cap
Mesoblast has a market cap or net worth of $2.24 billion as of February 3, 2026. Its market cap has increased by 14.59% in one year.
Market Cap
2.24B
Enterprise Value
2.20B
1-Year Change
14.59%
Ranking
Category
Stock Price
$17.19
Market Cap Chart
Since November 13, 2015, Mesoblast's market cap has increased from $593.20M to $2.24B, an increase of 277.17%. That is a compound annual growth rate of 13.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 2.21B | -4.38% |
| Dec 31, 2025 | 2.31B | 2.14% |
| Dec 31, 2024 | 2.26B | 1,162.26% |
| Dec 29, 2023 | 179.10M | -58.22% |
| Dec 30, 2022 | 428.70M | -31.15% |
| Dec 31, 2021 | 622.70M | -37.40% |
| Dec 31, 2020 | 994.70M | 35.19% |
| Dec 31, 2019 | 735.80M | 84.92% |
| Dec 31, 2018 | 397.90M | -27.59% |
| Dec 29, 2017 | 549.50M | 34.55% |
| Dec 30, 2016 | 408.40M | -12.21% |
| Dec 31, 2015 | 465.20M | -21.58% |
| Nov 13, 2015 | 593.20M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Spyre Therapeutics | 2.48B |
| Mineralys Therapeutics | 2.44B |
| Wave Life Sciences | 2.37B |
| Ultragenyx Pharmaceutical | 2.32B |
| Dianthus Therapeutics | 2.29B |
| Ascentage Pharma Group International | 2.27B |
| Galapagos NV | 2.23B |
| Recursion Pharmaceuticals | 2.18B |